|
|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 91 - 120 of 448 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
|
|
European Medicines Agency's website:
Adynovi - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Aerinaze - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Aerius - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Aerobec 50 ja 100 mikrog-annos inhalaatiosumute, liuos SPC 2020-09-29
|
|
PL
|
Resepti
|
Aerobec Autohaler 50 ja 100 mikrog-annos inhalaatiosumute, liuos SPC 2020-09-29
|
|
PL
|
Resepti
|
Aethoxysklerol 5 mg-ml, 10 mg-ml, 30 mg-ml injektioneste, liuos SPC 2020-11-09
|
|
|
|
European Medicines Agency's website:
Afinitor - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Aflunov - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Aforbe 100/6 mikrog/annos, inhalaatiosumute, liuos SPC 2023-08-15
|
|
|
|
European Medicines Agency's website:
Afstyla - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Aggrastat 250 mikrog - ml infuusiokonsentraatti, liuosta varten SPC 2021-11-04
|
|
PL
|
Resepti
|
Aggrastat 50 mikrog - ml infuusioneste, liuos SPC 2021-11-04
|
|
PL
|
Itsehoito
|
Agiocur rakeet SPC 2022-12-07
|
|
PL
|
Itsehoito
|
Agiolax rakeet SPC 2022-08-17
|
|
PL
|
Resepti
|
Agomelatine Mylan 25 mg tabletti, kalvopäällysteinen SPC 2021-04-19
|
|
PL
|
Resepti
|
Agomelatine ratiopharm 25 mg tabletti, kalvopäällysteinen SPC 2022-02-08
|
|
PL
|
Resepti
|
Agomelatine Stada 25 mg tabletti, kalvopäällysteinen SPC 2020-02-13
|
|
|
|
European Medicines Agency's website:
Aimovig - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Itsehoito
|
Airapy 100 % lääkkeellinen kaasu, puristettu SPC 2022-03-07
|
|
|
|
European Medicines Agency's website:
Airexar Spiromax - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Airomir 0,1 mg-annos inhalaatiosumute, suspensio SPC 2024-01-12
|
|
PL
|
Resepti
|
Airomir Autohaler 0,1 mg-annos inhalaatiosumute, suspensio SPC 2024-01-12
|
|
PL
|
Resepti
|
Aitgrys 100 RI & 300 RI, 300 RI resoribletti valmistusyhteenveto 2023-06-19
|
|
|
|
European Medicines Agency's website:
Ajovy - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Akineton 2 mg tabletti SPC 2023-09-29
|
|
PL
|
Resepti
|
Aklief 50 mikrog-g emulsiovoide SPC 2020-11-05
|
|
|
|
European Medicines Agency's website:
Akynzeo - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Alacare 8 mg lääkelaastari SPC 2022-01-24
|
|
PL
|
Resepti
|
Albetol 10 mg-ml injektioneste, liuos SPC 2023-10-05
|
|
PL
|
Resepti
|
Albetol 100 mg, 200 mg tabletti, kalvopäällysteinen SPC 2023-10-05
|
|
|
| |
